USPTO serial 79243427
CELLECTIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 24, 2020
- Examiner
- COLLOPY, DIANE PATRICIA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CELLECTIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Margaret L. O'Donnell
Mary Margaret L. O'Donnell Blue Filament Law PLLC700 E. Maple RoadSuite 450Birmingham, MI 48009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the treatment of cancer, immune system related diseases and disorders; microorganism cultures and nutritive substances for microorganism cultures for medical and pharmaceutical use; bacteriological preparations for medical and pharmaceutical use; biological preparations for medical and pharmaceutical use for treating cancer, immune system or genetic diseases or disorders, and malnutrition; chemical and biochemical preparations for medical, pharmaceutical, and therapeutic use for treating cancer and malnutrition; micro-organism preparations and cultures for medical, pharmaceutical and veterinary purposes; health food, beverages, preparations and substances, namely, dietetic foods for the treatment of celiac disease, nutritional supplements, medical preparations and substances for treatment of malnutrition, cancer, high cholesterol, cardiovascular disease, diabetes, coronary heart disease, immune system related diseases and disorders, nutritionally fortified beverages for medical purposes; plant-based health-food substances, namely, dietetic foods, namely, edible oils and fats, processed fruits and vegetables, preserved, dried and cooked fruits and vegetables, potato based snack food, soybeans based snack food, potato crisps, potato flakes and potato fritters, potato fries, cooked ready meals consisting primarily of vegetables, soya crisps, soya flakes, soya fries, corn-based snack food, wheat based snack foods, oat based snack foods, alfalfa based snack foods, coffee, coffee substitutes, seasonings, sauces and condiments, namely, mustard, ketchup and other tomatoes sauces, cooked ready meals consisting primarily of pasta or rice, potato, soya, corn, wheat, alfalfa or oat based foods, namely, puree, corn, wheat, alfalfa or oat crisps, soya, corn, wheat, alfalfa and oat flour, corn, wheat, alfalfa and oat flakes, corn, wheat, alfalfa and oat fries, adapted for medical use; dietary supplements; nutritional supplements; nutritional additives in the nature of dietary and nutritional supplements for medical purposes; cultures and preparations of micro-organisms for medical or therapeutic, pharmaceutical and veterinary use, namely, human and animal cells in the nature of biological tissue cultures for the treatment of cancer, immune system related diseases and disorders; bacteriological preparations for in vivo and in vitro genetic engineering, for medical, pharmaceutical and veterinary purposes; medicines for veterinary use for treating cancer and malnutrition; medicines for human use for treating cancer and malnutrition; Diagnostic preparations for the treatment of cancer, immune system related diseases and disorders, malnutrition; Pharmaceutical products for medical purposes in the nature of enzymes, namely, natural and engineered nucleases, nucleic acid vectors, molecular scissors; Chemical and pharmaceutical products for medical purposes in the nature of enzymes, namely, natural and engineered nucleases, nucleic acid vectors and molecular scissors; Veterinary products, namely, nucleic acid sequences being enzymes, stem cells, chemical and biological reagents, bacteria, yeasts, enzymes, bacteriological preparations, natural and engineered endoncucleases being enzymes | ACTIVE | — |
| 042 | Technical studies and evaluation of new products in the pharmaceutical industry; engineering services; computer programming; Design and development of computer software and hardware; scientific and industrial research in the agri-food, horticulture and agriculture sector for genome modification of cells of all types; genetic, medical and pharmaceutical research; research in chemistry, biology, biochemistry, molecular biology or bacteriology; research and development in biochemical analysis, biological analysis and molecular biology techniques; Research and development of new compounds for use in industry, agriculture and horticulture; scientific laboratory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 24, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 28, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 18, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 18, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 18, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 18, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 18, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 14, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 24, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 24, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 24, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 24, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 8, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 8, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 5, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 19, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 19, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 19, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 3, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 3, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 3, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 27, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jul 24, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 3, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 18, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 18, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 31, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 31, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 31, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 10, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 10, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 13, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 2, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 30, 2019 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 29, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 8, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 7, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 7, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 8, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 16, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 15, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 31, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 30, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 23, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 23, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 18, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |